LEXICON PHARMACEUTICALS, INC. (LXRX) Shareholders’ equity 2016–2025
LEXICON PHARMACEUTICALS, INC. (LXRX) shareholders’ equity at each fiscal year-end, per SEC filings.
$107.5MFY2025 · since FY2016: $167.5M → $107.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $107.5M | -26.3% |
| FY2024 | $145.9M | +56.8% |
| FY2023 | $93.1M | -20.5% |
| FY2022 | $117.1M | +3.1% |
| FY2021 | $113.6M | -27.4% |
| FY2020 | $156.4M | +33.5% |
| FY2019 | $117.1M | +543.5% |
| FY2018 | -$26.4M | -138.7% |
| FY2017 | $68.3M | -59.2% |
| FY2016 | $167.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice